A systematic review finds that diagnostic discordance in bone and soft tissue sarcoma may reduce survival, supporting expert second opinions.

Brian Balmes, based in Alpharetta, is a 27-year survivor of sarcoma, a rare and aggressive cancer. After his diagnosis, he turned to fitness as a way to cope — eventually training for and competing in ...

An oral combination treatment may prevent the progression of advanced leiomyosarcoma, one of the most common subtypes of soft ...

“By dividing and conquering…we’re seeing responses in multiple different subtypes of sarcoma…and moving toward more of an individualized therapy that we try to design for every patient, where we take ...

Cabozantinib plus temozolomide led to favorable short-term progression-free survival in a single-arm trial of patients with advanced leiomyosarcoma. The combination of cabozantinib with temozolomide ...

On World Cancer Day, NewsChannel 13 spoke to Casey Becker, a 26-year cancer survivor, and Nick Liporace from the American ...

ABU DHABI, 14th February, 2026 (WAM) -- Burjeel Cancer Institute (BCI) has announced the launch of its specialised Sarcoma & Bone Centre at Burjeel Medical City (BMC), the flagship facility of Burjeel ...

A major study by UCL and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) researchers has for the first time shown in detail how far ...

Malawi is facing a worrying rise in cases of Kaposi sarcoma, a form of cancer that mainly attacks people with weakened immune systems, health authorities have warned.Officials from the Ministry of ...